Antiretroviral potential of human tripartite motif-5 and related proteins (Q34545890)

2 August 2017

Antiretroviral potential of human tripartite motif-5 and related proteins (English)

1 reference

2 August 2017

anti-retroviral agent

0 references

5

Paul D Bieniasz

1 reference

2 August 2017

Fengwen Zhang

1

1 reference

2 August 2017

Theodora Hatziioannou

series ordinal

2

1 reference

2 August 2017

David Perez-Caballero

series ordinal

3

1 reference

2 August 2017

David Derse

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

10 July 2006

1 reference

2 August 2017

14

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

2 August 2017

353

1 reference

2 August 2017

396-409

1 reference

2 August 2017

2

1 reference

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Murine T cells potently restrict human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Positional cloning of the mouse retrovirus restriction gene Fv1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Intrinsic immunity: a front-line defense against viral attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Use of a transient assay for studying the genetic determinants of Fv1 restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Genetic control of retrovirus susceptibility in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

DNA deamination mediates innate immunity to retroviral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Restriction of multiple divergent retroviruses by Lv1 and Ref1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

An envelope-determined, pH-independent endocytic route of viral entry determines the susceptibility of human immunodeficiency virus type 1 (HIV-1) and HIV-2 to Lv2 restriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Stable gene transfer to the nervous system using a non-primate lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Molecular phylogeny of Fv1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Role of HIV-2 envelope in Lv2-mediated restriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

The tripartite motif family identifies cell compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Host cyclophilin A mediates HIV-1 attachment to target cells via heparans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Lv2, a novel postentry restriction, is mediated by both capsid and envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

TRIM5alpha selectively binds a restriction-sensitive retroviral capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Retrovirus restriction by TRIM5alpha variants from Old World and New World primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Retroviral capsid determinants of Fv1 NB and NR tropism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Trim5alpha protein restricts both HIV-1 and murine leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Molecular recognition in the HIV-1 capsid/cyclophilin A complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.05.035

1 reference

2 August 2017

1 reference